Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | 3 | — | — | — | 3 |
Dyskinesias | D020820 | HP_0002310 | G24 | — | 1 | — | — | — | 1 |
Drug-induced abnormalities | D000014 | — | — | — | 1 | — | — | — | 1 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
Amnesia | D000647 | EFO_1001454 | F44.0 | — | 1 | — | — | — | 1 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | AQW051 |
INN | — |
Description | Aqw051 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1ccc(-c2ccc(OC3CN4CCC3CC4)cn2)cc1 |
PDB | — |
CAS-ID | 669770-29-0 |
RxCUI | — |
ChEMBL ID | CHEMBL3545232 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |